Adrenomedullin expression during hypoxia in fetal sheep.
OBJECTIVE
We asked how adrenomedullin (AM), a vasodilator peptide, was distributed in fetal sheep organs and whether expression of AM would be upregulated in response to moderate acute fetal hypoxia in vivo.


METHODS
In four sheep at day 126-130 of gestation, nitrogen was added to the inspired air by tracheal infusion to reduce fetal arterial oxygen content for a period of 4 h. Control fetuses were from four ewes given a tracheal infusion of room air. Fetal and maternal blood samples were taken prior to and during hypoxia/sham hypoxia. Fetal tissue samples were frozen for RNA analysis and fixed for immunohistochemistry.


RESULTS
In hypoxic fetuses, arterial oxygen content was significantly reduced to 50% compared with sham fetuses with no change in arterial pH in either group. Plasma ACTH levels rose significantly at 2 and 4 h in hypoxic fetuses only. Initial plasma concentrations of AM in control and hypoxic fetuses were 457 +/- 20 and 430 +/- 35 pg mL(-1) and did not change during the experiment. The relative abundance of AM mRNA was placental cotyledons >> lung > cerebral cortex approximately equal to renal cortex > left ventricle approximately equal to right ventricle > adrenal gland > renal medulla > aorta approximately equal to liver. Immunohistochemical staining for AM confirmed distinct labelling in organs with significant expression. AM mRNA level increased significantly in cerebral cortex of hypoxic fetuses.


CONCLUSIONS
Our results show expression of AM in placenta and in several fetal organs in late gestation sheep. AM may participate in the cerebral vasodilatation that is an integral part of the fetal response to hypoxia.
Jensen
R I
RI
Department of Physiology and Pharmacology, University of Southern Denmark, Odense, Denmark.
Carter
A M
AM
Skøtt
O
O
Jensen
B L
BL
D000199:Actins / Q000032:analysis; D000324:Adrenocorticotropic Hormone / Q000097:blood; D053607:Adrenomedullin; D000818:Animals; D002540:Cerebral Cortex / Q000196:embryology / Q000378:metabolism; D005260:Female; D005312:Fetal Blood / Q000378:metabolism; D005311:Fetal Hypoxia / Q000378:metabolism*; D006863:Hydrogen-Ion Concentration; D007150:Immunohistochemistry / Q000379:methods; D007668:Kidney / Q000196:embryology / Q000378:metabolism; D008297:Male; D010100:Oxygen / Q000097:blood; D010455:Peptides / Q000032:analysis* / Q000097:blood; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D012333:RNA, Messenger / Q000032:analysis; D012756:Sheep; D015854:Up-Regulation / Q000502:physiology; D014665:Vasodilator Agents / Q000032:analysis* / Q000097:blood
D000199:Actins; D010455:Peptides; D012333:RNA, Messenger; D014665:Vasodilator Agents; D053607:Adrenomedullin; D000324:Adrenocorticotropic Hormone; D010100:Oxygen